Portable, enhanced SERS technology delivers sensitivity comparable to (or better than) PCR and identifies harmful food pathogens at various links in the “seed-to-shelf” chain within 1 minute of sample preparation. can be specified.
NEW YORK and ROSEMONT, IL, May 6, 2024–(BUSINESS WIRE)–NOMADX Holdings, LLC, a pioneer in new technologies for biological and chemical detection, today announced early access to the portable NOMADX announced the start of the program. A platform aimed at enabling faster and more accurate on-site pathogen detection in food safety applications. As a Platinum Sponsor, the company will present an overview of the NOMADX platform at the Food Safety Summit in Rosemont, Illinois, May 6-9, 2024, as well as present an overview of current and future technologies and autonomous pipes. Discuss line applications.
The NOMADX cartridge-enhanced SERS platform, which leverages technology initially licensed from leading universities and subsequently refined, is a patented surface coating applied to silicon chips using metal nanoparticles. This new technique creates a platform that significantly enhances the electromagnetic and chemical spectral scattering signals of molecules within the sample. Internal validation studies demonstrated that these enhancements enable detection and quantification of a wide range of analytes at the single-molecule detection level. However, further research has shown that NOMADX is as quick and easy to use as ATP-based tests, and provides results that exceed the sensitivity, specificity, and speed (1-minute results) of traditional PCR tests. Masu.
“The food industry stands to benefit greatly from technological innovations that enable more accurate testing methods that can be performed by anyone. Traditional approaches such as quantitative PCR assays and DNA sequencing They often suffer from delays due to complex sample preparation protocols,” said Dr. Rupesh Chaturvedi, Scientific Advisor, NOMADX Holdings LLC. “The NOMADX platform addresses this challenge by leveraging state-of-the-art cartridge-based technology to provide decentralized on-site testing capabilities that significantly improve the pace and accuracy of food safety assessments.”
The Centers for Disease Control and Prevention estimates that about 1 in 6 Americans, or about 48 million people, get sick each year, with about 128,000 hospitalizations and 3,000 deaths from foodborne illnesses. [Source] This is a preventable public health challenge costing billions of dollars. The World Health Organization estimates that food poisoning affects an estimated 600 million people worldwide, or nearly 1 in 10 people, who become ill after eating contaminated food, resulting in 420,000 deaths each year. It is estimated that 33 million years of healthy life expectancy have been lost as a result. Currently, quantitative PCR assays and DNA sequencing are the most common methods used to detect pathogens and identify food components. However, these methods often require specialized technical expertise and shipping of samples to central processing labs, and results can take days to weeks to arrive. Technologies that enable decentralized on-site testing have the potential to increase the pace of testing and further ensure that food is pathogen-free and safe for consumption.
story continues
“As foodborne illness continues to pose a significant threat to public health, better testing methods are urgently needed to reduce risk and ensure consumer safety. Rapid pathogen detection in the field The NOMADX platform's ability to deliver “faster and more accurate results without the need for extensive laboratory infrastructure or specialized training'' represents a significant evolution in this regard. said Anjan Chatterji, JD, MBA, LLM, CEO and Co-Founder of NOMADX Holdings.
The NOMADX sample collection protocol is designed for use by technical and non-technical personnel alike and is similar to the ATP test, which uses a wet cotton swab to sample a defined surface. The collected sample is placed into a cartridge containing a patented chip. Each cartridge is read in less than a minute on a handheld device, providing laboratory-grade results. Additionally, the spectral data is analyzed with his NOMADX data library and AI-based algorithms for instant results. This NOMADX protocol does not destroy the sample, so the cartridge and sample can be saved for confirmatory testing. All tests can be performed at the point of sampling without the need for laboratory equipment or specialized training.
The early access program is open to producers/farmers, food processors, distribution, retail/foodservice, and regulatory agencies seeking innovative new pathogen testing solutions. For more information about the NOMADX Early Access Program, please visit www.nomadxholdings.com/earlyaccess.
About NOMADX Holdings
NOMADX Holdings LLC develops new products for biological and chemical detection, including innovative products that enable faster and more accurate testing in food, water, and air safety as well as human healthcare applications. A pioneer in technology. To learn more about NOMADX and its mission to be a natural selection in the evolution of diagnostics, please visit www.nomadxholdings.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240506019822/en/
contact address
media@nomadxholdings.com